Solid Biosciences (SLDB) Return on Equity (2018 - 2026)
Quarterly results put Return on Equity at 0.01% for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was 0.01% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, changed 0.0%.
Solid Biosciences has reported Return on Equity over the past 9 years, most recently at 0.01% for Q1 2026.
- Return on Equity reached 0.01% in Q1 2026 per SLDB's latest filing, up from 0.01% in the prior quarter.
- Across five years, Return on Equity topped out at 0.0% in Q1 2022 and bottomed at 0.01% in Q4 2025.
- Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
- Peak annual rise in Return on Equity hit 0bps in 2022, while the deepest fall reached 0bps in 2022.
- Over 5 years, Return on Equity stood at 0.01% in 2022, then dropped by -23bps to 0.01% in 2023, then dropped by -11bps to 0.01% in 2024, then decreased by -7bps to 0.01% in 2025, then grew by 21bps to 0.01% in 2026.
- Business Quant data shows Return on Equity for SLDB at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -0.04% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.00% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.00% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.01% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.03% |
| Jun 30, 2020 | -0.02% |
| Mar 31, 2020 | -0.02% |
| Dec 31, 2019 | -0.01% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -0.01% |